These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3233579)

  • 1. Hormonal therapy for breast cancer.
    Dunne CF
    Cancer Nurs; 1988 Oct; 11(5):288-94. PubMed ID: 3233579
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro hormone tests in human breast cancers and their relevance for therapy of metastasizing breast cancer].
    Schönfelder M
    Zentralbl Chir; 1987; 112(18):1150-4. PubMed ID: 3687263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer.
    Bodmer A; Castiglione-Gertsch M
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S28-37. PubMed ID: 21943985
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-aromatase acting drugs].
    Diedrich K
    Krankenpfl J; 2005; 43(4-6):150-1. PubMed ID: 16171094
    [No Abstract]   [Full Text] [Related]  

  • 5. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Palliative hormone therapy of advanced breast cancer].
    Schröder W
    Gynakologe; 1993 Apr; 26(2):131-6. PubMed ID: 7685310
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent topics in endocrine therapy for hormone-dependent breast cancer: basic research and clinical applications.
    Kimijima I
    Breast Cancer; 2008; 15(4):253-5. PubMed ID: 18953680
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
    Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid receptors in adjuvant hormonal therapy for breast cancer.
    Goldie JH; Bruchovsky N; Coldman AJ; Gudauskas GA
    Can J Surg; 1981 May; 24(3):290-3. PubMed ID: 7237303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemo-radiation in the conservative management of breast cancer: In regard to Haffty et al. (Int J Radiat Oncol Biol Phys 2006;65:1306-1312).
    Tiwana MS
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):639; author reply 639. PubMed ID: 17236981
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with hormone therapy and with the prevention of generalization of breast cancer].
    Holecek V; Lhotka J; Borek Z
    Sb Lek; 1967 Aug; 69(8):243-50. PubMed ID: 6077250
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-hormonal therapy in breast cancer].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1994 Aug; 17(8):247-50. PubMed ID: 7935152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aromatase inhibitors in the adjuvant therapy of breast cancer].
    Bauerschlag D; Schem C; Maass N; Jonat W
    Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):132-6. PubMed ID: 15990437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors].
    Ohtake T; Yasuda M; Watanabe K; Ito T; Ito J; Miyamoto K; Yoshida S; Abe N; Ishigame T; Ishii M; Kimijima I; Takenoshita S
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1459-63. PubMed ID: 19755813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant treatment of breast cancer.
    Akerley WL
    R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
    [No Abstract]   [Full Text] [Related]  

  • 16. Breast cancer: metastatic.
    Johnston S; Stebbing J
    Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
    [No Abstract]   [Full Text] [Related]  

  • 17. [Extended adjuvant hormone therapy (in breast cancer): Why? To whom? What? How long?].
    Kahán Z
    Magy Onkol; 2008 Jun; 52(2):225-6. PubMed ID: 18640899
    [No Abstract]   [Full Text] [Related]  

  • 18. [The hormone and chemotherapy in female metastatic breast cancer (author's transl)].
    Obrecht JP; Nagel GA; Mayr AC
    Schweiz Rundsch Med Prax; 1974 Jan; 63(4):109-14. PubMed ID: 4411163
    [No Abstract]   [Full Text] [Related]  

  • 19. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating epithelial cells in breast cancer.
    Tang C; Lin AY
    N Engl J Med; 2004 Dec; 351(23):2452-4; author reply 2452-4. PubMed ID: 15580681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.